Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsSEC EDGAR SCHEDULE 13GFiled 2 days ago

RIGEL PHARMACEUTICALS INC: AMERICAN CENTURY INVESTMENT MANAGEMENT INC discloses a stake of more than 5% (Schedule 13G)

Open the sourceReported by SEC EDGAR SCHEDULE 13G, sec.gov, 16 November 2026, by SEC EDGAR SCHEDULE 13G

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

American Century Investment Management Inc. disclosed a stake of more than 5% in Rigel Pharmaceuticals Inc. in a Schedule 13G filing with the SEC (accession 0000052388-26-000507). The filing signals that the asset manager has crossed the 5% beneficial ownership threshold, making it a reportable large holder in the biopharmaceutical company. The exact share count and percentage were not specified in the headline disclosure. The move matters because 13G filings flag passive or institutional accumulation that can influence governance and liquidity in a small-cap stock. Investors will watch for the full filing details, including precise ownership figures and any subsequent 13G amendments.

Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.

Named in this story

American Century Investment Management Inc, Rigel Pharmaceuticals Inc